Anti-Covid medicine successfully produced

Myanmar FDA-recommended Paclovid (oral drug) for Covid-19.

Anti-Covid medicine will be produced when an order is received from the Ministry of Health, according to the Myanma Pharmaceutical Industry, Ministry of Industry.
Myanma Pharmaceutical Industry produces various kinds of medicines, including Covid vaccines, for the Ministry of Health and has been producing K55 billion worth of COVID vaccines since the outbreak of the pandemic.
Paclovid (Nirmatrelvir 150 mg + Ritonavir 100 mg) is a kind of Covid drug.
A packet of Paclovid (30 capsules) costs K250,000 and is available only on prescription, according to Pacific Medical Industries.
Pacific Medical Industries Ltd successfully produced the medicine with Myanmar FDA recommendation number (2308ND 012). The medicine is also recommended by WHO, US FDA, UK MHRA, Korean FDA, and Singapore FDA. — TWA/GNLM

Share this post
Hot News
Hot News
Bago’s Shwemawdaw Pagoda to host rice offering, watering banyan tree
Myanmar’s intangible cultural heritage: Preserving tug-of-war competitions amidst constructive criticism
Snakes seek shelter indoors to escape intense heat
Summer revellers flock to Dokhtawadi River for water play
Mandalay’s oxygen cylinder rentals surge as elderly grapple with low O2 levels amid heat wave
59th Myanmar Gems Emporium Day 2: 182 pearl lots sold
147th Anniversary of Myanma Railways marked
False news: 3 citizens from Pyasakan village die from heavy weapons by security forces
AA terrorists intentionally launch heavy weapons on IDPs
Kayin State Chief Minister makes inspection tours in Hpa-an